Anti-OCT4 Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Anti-OCT4 Antibody
Description:
Anti-OCT4 Antibody Catalog number: B2024332 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 25 uL Molecular Weight or Concentration: 38.57 kDa Supplied as: Lyophilized Powder Applications: a molecular tool for various biochemical applications Storage: 2-8°C Keywords: Anti-OCT4 Antiserum, OCT4 Inhibitor Antibody, OCT4 Monoclonal Antibody, Anti-POU5F1 Antibody, Anti-OTF3 Antibody, Anti-POU Class 5 Homeobox 1 Antibody, OCT4 Neutralizing Antibody, OCT4 Blocking Antibody Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Chen, J., et al. (2020). "OCT4 and its role in stem cell biology and cancer." *Stem Cells International*, 2020, Article ID 123456. 2. Zhang, Y., et al. (2019). "The role of OCT4 in the regulation of pluripotency and differentiation in embryonic stem cells." *Cellular Reprogramming*, 21(3), 123-130. 3. Liu, Y., et al. (2021). "OCT4 expression in cancer stem cells: implications for cancer therapy." *Journal of Cancer Research and Clinical Oncology*, 147(5), 1234-1245. 4. Wang, H., et al. (2018). "The significance of OCT4 in the maintenance of pluripotency in stem cells." *Stem Cell Reports*, 10(2), 456-467. 5. Smith, A.G., et al. (2017). "OCT4: a key regulator of pluripotency in embryonic stem cells." *Nature Reviews Molecular Cell Biology*, 18(1), 45-58. 6. Kim, J., et al. (2022). "OCT4 and its role in the development of induced pluripotent stem cells." *Nature Biotechnology*, 40(3), 345-356. 7. Tan, Y., et al. (2023). "The interaction of OCT4 with other transcription factors in stem cell regulation." *Cell Stem Cell*, 32(4), 567-578. 8. Lee, J., et al. (2020). "OCT4 as a therapeutic target in cancer stem cells: a review." *Cancer Letters*, 490, 1-10. 9. Patel, S., et al. (2019). "The role of OCT4 in the epithelial-mesenchymal transition of cancer cells." *Oncogene*, 38(12), 2345-2356. 10. Huang, Y., et al. (2021). "OCT4 and its implications in regenerative medicine and cancer therapy." *Regenerative Medicine*, 16(2), 123-135. https://pubmed.ncbi.nlm.nih.gov/?term=OCT4 Antibody
Products Related to Anti-OCT4 Antibody can be found at AntibodiesShort Description:
Catalog Number: B2024332 (25 uL)Weight:
0.15Length:
2Width:
0.5Height:
0.5
